Friday 21 November, 2014

New therapeutic target for treatment of cancer cells identified

Published On: Sat, Oct 22nd, 2011 | Developmental Biology | By BioNews

US scientists have identified a cell cycle-regulated mechanism behind the transformation of normal cells into cancerous cells.

The study, by the NYU Cancer Institute, an NCI-designated cancer center at NYU Langone Medical Center, shows the significant role that protein networks can play in a cell leading to the development of cancer.

The study results suggest that inhibition of the CK1 enzyme may be a new therapeutic target for the treatment of cancer cells formed as a result of a malfunction in the cell’s mTOR signaling pathway.

The study has been published in the journal Molecular Cell.

Leave a comment

XHTML: You can use these html tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

More from Developmental Biology
  • World’s number of IVF and ICSI babies reach 5 million mark
  • Rats exhibit human-like empathy to help ‘distressed’ fellow rodents
  • Diabetes drug could help cut risk of cancer
  • New ‘tumour-seeking’ drug brings new hope for cancer patients
  • Soon, wonder drug to make cancer cells ‘commit suicide’
  • Visit us on Google+